The global market for Aesthetic Injectables was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance

The total size of the global beauty industry in 2022 was about US$ 427 billion, with the sales of skin care products was about US$ 190 billion, perfumes US$ 70 billion, color cosmetics US$ 80 billion, hair care products US$ 90 billion. Head beauty and personal care companies are concentrated in Europe and the United States. More than one-third of the top 100 companies are headquartered in the United States, and 22.9% of the companies are located in France.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aesthetic Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aesthetic Injectables.

The Aesthetic Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aesthetic Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aesthetic Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Aesthetic Injectables Market Report

Report Metric	Details
Report Name	Aesthetic Injectables Market
Segment by Type	Sunken Cheeks or Temples Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines) Plumping Up Lips Enhancing Facial Contour
Segment by Application	Hospital Beauty Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Allergan Plc, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Plc, Teoxane SA, Bohus BioTech AB, AbbVie Inc, Huadong Medicine Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aesthetic Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aesthetic Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Aesthetic Injectables Market report?

Ans: The main players in the Aesthetic Injectables Market are Allergan Plc, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Plc, Teoxane SA, Bohus BioTech AB, AbbVie Inc, Huadong Medicine Co., Ltd

What are the Application segmentation covered in the Aesthetic Injectables Market report?

Ans: The Applications covered in the Aesthetic Injectables Market report are Hospital, Beauty Clinic

What are the Type segmentation covered in the Aesthetic Injectables Market report?

Ans: The Types covered in the Aesthetic Injectables Market report are Sunken Cheeks or Temples, Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines), Plumping Up Lips, Enhancing Facial Contour

1 Aesthetic Injectables Market Overview

1.1 Product Definition

1.2 Aesthetic Injectables by Type

1.2.1 Global Aesthetic Injectables Market Value Comparison by Type (2024 VS 2031)

1.2.2 Sunken Cheeks or Temples

1.2.3 Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)

1.2.4 Plumping Up Lips

1.2.5 Enhancing Facial Contour

1.3 Aesthetic Injectables by Application

1.3.1 Global Aesthetic Injectables Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Beauty Clinic

1.4 Global Aesthetic Injectables Market Size Estimates and Forecasts

1.4.1 Global Aesthetic Injectables Revenue 2020-2031

1.4.2 Global Aesthetic Injectables Sales 2020-2031

1.4.3 Global Aesthetic Injectables Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Aesthetic Injectables Market Competition by Manufacturers

2.1 Global Aesthetic Injectables Sales Market Share by Manufacturers (2020-2025)

2.2 Global Aesthetic Injectables Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Aesthetic Injectables Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Aesthetic Injectables, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Aesthetic Injectables, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Aesthetic Injectables, Product Type & Application

2.7 Global Key Manufacturers of Aesthetic Injectables, Date of Enter into This Industry

2.8 Global Aesthetic Injectables Market Competitive Situation and Trends

2.8.1 Global Aesthetic Injectables Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Aesthetic Injectables Players Market Share by Revenue

2.8.3 Global Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Aesthetic Injectables Market Scenario by Region

3.1 Global Aesthetic Injectables Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Aesthetic Injectables Sales by Region: 2020-2031

3.2.1 Global Aesthetic Injectables Sales by Region: 2020-2025

3.2.2 Global Aesthetic Injectables Sales by Region: 2026-2031

3.3 Global Aesthetic Injectables Revenue by Region: 2020-2031

3.3.1 Global Aesthetic Injectables Revenue by Region: 2020-2025

3.3.2 Global Aesthetic Injectables Revenue by Region: 2026-2031

3.4 North America Aesthetic Injectables Market Facts & Figures by Country

3.4.1 North America Aesthetic Injectables Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Aesthetic Injectables Sales by Country (2020-2031)

3.4.3 North America Aesthetic Injectables Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Aesthetic Injectables Market Facts & Figures by Country

3.5.1 Europe Aesthetic Injectables Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Aesthetic Injectables Sales by Country (2020-2031)

3.5.3 Europe Aesthetic Injectables Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Aesthetic Injectables Market Facts & Figures by Region

3.6.1 Asia Pacific Aesthetic Injectables Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Aesthetic Injectables Sales by Region (2020-2031)

3.6.3 Asia Pacific Aesthetic Injectables Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Aesthetic Injectables Market Facts & Figures by Country

3.7.1 Latin America Aesthetic Injectables Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Aesthetic Injectables Sales by Country (2020-2031)

3.7.3 Latin America Aesthetic Injectables Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Aesthetic Injectables Market Facts & Figures by Country

3.8.1 Middle East and Africa Aesthetic Injectables Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Aesthetic Injectables Sales by Country (2020-2031)

3.8.3 Middle East and Africa Aesthetic Injectables Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Aesthetic Injectables Sales by Type (2020-2031)

4.1.1 Global Aesthetic Injectables Sales by Type (2020-2025)

4.1.2 Global Aesthetic Injectables Sales by Type (2026-2031)

4.1.3 Global Aesthetic Injectables Sales Market Share by Type (2020-2031)

4.2 Global Aesthetic Injectables Revenue by Type (2020-2031)

4.2.1 Global Aesthetic Injectables Revenue by Type (2020-2025)

4.2.2 Global Aesthetic Injectables Revenue by Type (2026-2031)

4.2.3 Global Aesthetic Injectables Revenue Market Share by Type (2020-2031)

4.3 Global Aesthetic Injectables Price by Type (2020-2031)

5 Segment by Application

5.1 Global Aesthetic Injectables Sales by Application (2020-2031)

5.1.1 Global Aesthetic Injectables Sales by Application (2020-2025)

5.1.2 Global Aesthetic Injectables Sales by Application (2026-2031)

5.1.3 Global Aesthetic Injectables Sales Market Share by Application (2020-2031)

5.2 Global Aesthetic Injectables Revenue by Application (2020-2031)

5.2.1 Global Aesthetic Injectables Revenue by Application (2020-2025)

5.2.2 Global Aesthetic Injectables Revenue by Application (2026-2031)

5.2.3 Global Aesthetic Injectables Revenue Market Share by Application (2020-2031)

5.3 Global Aesthetic Injectables Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Allergan Plc

6.1.1 Allergan Plc Company Information

6.1.2 Allergan Plc Description and Business Overview

6.1.3 Allergan Plc Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Allergan Plc Aesthetic Injectables Product Portfolio

6.1.5 Allergan Plc Recent Developments/Updates

6.2 Galderma SA

6.2.1 Galderma SA Company Information

6.2.2 Galderma SA Description and Business Overview

6.2.3 Galderma SA Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Galderma SA Aesthetic Injectables Product Portfolio

6.2.5 Galderma SA Recent Developments/Updates

6.3 Merz Pharma GmbH & Co KgaA

6.3.1 Merz Pharma GmbH & Co KgaA Company Information

6.3.2 Merz Pharma GmbH & Co KgaA Description and Business Overview

6.3.3 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product Portfolio

6.3.5 Merz Pharma GmbH & Co KgaA Recent Developments/Updates

6.4 Sinclair Pharma Plc

6.4.1 Sinclair Pharma Plc Company Information

6.4.2 Sinclair Pharma Plc Description and Business Overview

6.4.3 Sinclair Pharma Plc Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sinclair Pharma Plc Aesthetic Injectables Product Portfolio

6.4.5 Sinclair Pharma Plc Recent Developments/Updates

6.5 Teoxane SA

6.5.1 Teoxane SA Company Information

6.5.2 Teoxane SA Description and Business Overview

6.5.3 Teoxane SA Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Teoxane SA Aesthetic Injectables Product Portfolio

6.5.5 Teoxane SA Recent Developments/Updates

6.6 Bohus BioTech AB

6.6.1 Bohus BioTech AB Company Information

6.6.2 Bohus BioTech AB Description and Business Overview

6.6.3 Bohus BioTech AB Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bohus BioTech AB Aesthetic Injectables Product Portfolio

6.6.5 Bohus BioTech AB Recent Developments/Updates

6.7 AbbVie Inc

6.7.1 AbbVie Inc Company Information

6.7.2 AbbVie Inc Description and Business Overview

6.7.3 AbbVie Inc Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.7.4 AbbVie Inc Aesthetic Injectables Product Portfolio

6.7.5 AbbVie Inc Recent Developments/Updates

6.8 Huadong Medicine Co., Ltd

6.8.1 Huadong Medicine Co., Ltd Company Information

6.8.2 Huadong Medicine Co., Ltd Description and Business Overview

6.8.3 Huadong Medicine Co., Ltd Aesthetic Injectables Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Huadong Medicine Co., Ltd Aesthetic Injectables Product Portfolio

6.8.5 Huadong Medicine Co., Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Aesthetic Injectables Industry Chain Analysis

7.2 Aesthetic Injectables Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Aesthetic Injectables Production Mode & Process Analysis

7.4 Aesthetic Injectables Sales and Marketing

7.4.1 Aesthetic Injectables Sales Channels

7.4.2 Aesthetic Injectables Distributors

7.5 Aesthetic Injectables Customer Analysis

8 Aesthetic Injectables Market Dynamics

8.1 Aesthetic Injectables Industry Trends

8.2 Aesthetic Injectables Market Drivers

8.3 Aesthetic Injectables Market Challenges

8.4 Aesthetic Injectables Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Allergan plc

Galderma SA

Merz Pharma GmbH & Co KgaA

Huadong Medicine Co.,Ltd

List of Tables

Table 1. Global Aesthetic Injectables Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Aesthetic Injectables Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Aesthetic Injectables Market Competitive Situation by Manufacturers in 2024

Table 4. Global Aesthetic Injectables Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Aesthetic Injectables Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Aesthetic Injectables Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Aesthetic Injectables Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Aesthetic Injectables Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Aesthetic Injectables, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Aesthetic Injectables, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Aesthetic Injectables, Product Type & Application

Table 12. Global Key Manufacturers of Aesthetic Injectables, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Aesthetic Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aesthetic Injectables as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Aesthetic Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Aesthetic Injectables Sales by Region (2020-2025) & (K Units)

Table 18. Global Aesthetic Injectables Sales Market Share by Region (2020-2025)

Table 19. Global Aesthetic Injectables Sales by Region (2026-2031) & (K Units)

Table 20. Global Aesthetic Injectables Sales Market Share by Region (2026-2031)

Table 21. Global Aesthetic Injectables Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Aesthetic Injectables Revenue Market Share by Region (2020-2025)

Table 23. Global Aesthetic Injectables Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Aesthetic Injectables Revenue Market Share by Region (2026-2031)

Table 25. North America Aesthetic Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Aesthetic Injectables Sales by Country (2020-2025) & (K Units)

Table 27. North America Aesthetic Injectables Sales by Country (2026-2031) & (K Units)

Table 28. North America Aesthetic Injectables Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Aesthetic Injectables Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Aesthetic Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Aesthetic Injectables Sales by Country (2020-2025) & (K Units)

Table 32. Europe Aesthetic Injectables Sales by Country (2026-2031) & (K Units)

Table 33. Europe Aesthetic Injectables Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Aesthetic Injectables Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Aesthetic Injectables Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Aesthetic Injectables Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Aesthetic Injectables Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Aesthetic Injectables Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Aesthetic Injectables Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Aesthetic Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Aesthetic Injectables Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Aesthetic Injectables Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Aesthetic Injectables Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Aesthetic Injectables Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Aesthetic Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Aesthetic Injectables Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Aesthetic Injectables Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Aesthetic Injectables Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Aesthetic Injectables Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Aesthetic Injectables Sales (K Units) by Type (2020-2025)

Table 51. Global Aesthetic Injectables Sales (K Units) by Type (2026-2031)

Table 52. Global Aesthetic Injectables Sales Market Share by Type (2020-2025)

Table 53. Global Aesthetic Injectables Sales Market Share by Type (2026-2031)

Table 54. Global Aesthetic Injectables Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Aesthetic Injectables Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Aesthetic Injectables Revenue Market Share by Type (2020-2025)

Table 57. Global Aesthetic Injectables Revenue Market Share by Type (2026-2031)

Table 58. Global Aesthetic Injectables Price (US$/Unit) by Type (2020-2025)

Table 59. Global Aesthetic Injectables Price (US$/Unit) by Type (2026-2031)

Table 60. Global Aesthetic Injectables Sales (K Units) by Application (2020-2025)

Table 61. Global Aesthetic Injectables Sales (K Units) by Application (2026-2031)

Table 62. Global Aesthetic Injectables Sales Market Share by Application (2020-2025)

Table 63. Global Aesthetic Injectables Sales Market Share by Application (2026-2031)

Table 64. Global Aesthetic Injectables Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Aesthetic Injectables Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Aesthetic Injectables Revenue Market Share by Application (2020-2025)

Table 67. Global Aesthetic Injectables Revenue Market Share by Application (2026-2031)

Table 68. Global Aesthetic Injectables Price (US$/Unit) by Application (2020-2025)

Table 69. Global Aesthetic Injectables Price (US$/Unit) by Application (2026-2031)

Table 70. Allergan Plc Company Information

Table 71. Allergan Plc Description and Business Overview

Table 72. Allergan Plc Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Allergan Plc Aesthetic Injectables Product

Table 74. Allergan Plc Recent Developments/Updates

Table 75. Galderma SA Company Information

Table 76. Galderma SA Description and Business Overview

Table 77. Galderma SA Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Galderma SA Aesthetic Injectables Product

Table 79. Galderma SA Recent Developments/Updates

Table 80. Merz Pharma GmbH & Co KgaA Company Information

Table 81. Merz Pharma GmbH & Co KgaA Description and Business Overview

Table 82. Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product

Table 84. Merz Pharma GmbH & Co KgaA Recent Developments/Updates

Table 85. Sinclair Pharma Plc Company Information

Table 86. Sinclair Pharma Plc Description and Business Overview

Table 87. Sinclair Pharma Plc Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Sinclair Pharma Plc Aesthetic Injectables Product

Table 89. Sinclair Pharma Plc Recent Developments/Updates

Table 90. Teoxane SA Company Information

Table 91. Teoxane SA Description and Business Overview

Table 92. Teoxane SA Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Teoxane SA Aesthetic Injectables Product

Table 94. Teoxane SA Recent Developments/Updates

Table 95. Bohus BioTech AB Company Information

Table 96. Bohus BioTech AB Description and Business Overview

Table 97. Bohus BioTech AB Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Bohus BioTech AB Aesthetic Injectables Product

Table 99. Bohus BioTech AB Recent Developments/Updates

Table 100. AbbVie Inc Company Information

Table 101. AbbVie Inc Description and Business Overview

Table 102. AbbVie Inc Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. AbbVie Inc Aesthetic Injectables Product

Table 104. AbbVie Inc Recent Developments/Updates

Table 105. Huadong Medicine Co., Ltd Company Information

Table 106. Huadong Medicine Co., Ltd Description and Business Overview

Table 107. Huadong Medicine Co., Ltd Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Huadong Medicine Co., Ltd Aesthetic Injectables Product

Table 109. Huadong Medicine Co., Ltd Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Aesthetic Injectables Distributors List

Table 113. Aesthetic Injectables Customers List

Table 114. Aesthetic Injectables Market Trends

Table 115. Aesthetic Injectables Market Drivers

Table 116. Aesthetic Injectables Market Challenges

Table 117. Aesthetic Injectables Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Aesthetic Injectables

Figure 2. Global Aesthetic Injectables Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Aesthetic Injectables Market Share by Type: 2024 & 2031

Figure 4. Sunken Cheeks or Temples Product Picture

Figure 5. Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines) Product Picture

Figure 6. Plumping Up Lips Product Picture

Figure 7. Enhancing Facial Contour Product Picture

Figure 8. Global Aesthetic Injectables Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Aesthetic Injectables Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Beauty Clinic

Figure 12. Global Aesthetic Injectables Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Aesthetic Injectables Market Size (2020-2031) & (US$ Million)

Figure 14. Global Aesthetic Injectables Sales (2020-2031) & (K Units)

Figure 15. Global Aesthetic Injectables Average Price (US$/Unit) & (2020-2031)

Figure 16. Aesthetic Injectables Report Years Considered

Figure 17. Aesthetic Injectables Sales Share by Manufacturers in 2024

Figure 18. Global Aesthetic Injectables Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Aesthetic Injectables Players: Market Share by Revenue in Aesthetic Injectables in 2024

Figure 20. Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Aesthetic Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Aesthetic Injectables Sales Market Share by Country (2020-2031)

Figure 23. North America Aesthetic Injectables Revenue Market Share by Country (2020-2031)

Figure 24. United States Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Aesthetic Injectables Sales Market Share by Country (2020-2031)

Figure 27. Europe Aesthetic Injectables Revenue Market Share by Country (2020-2031)

Figure 28. Germany Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Aesthetic Injectables Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Aesthetic Injectables Revenue Market Share by Region (2020-2031)

Figure 35. China Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Aesthetic Injectables Sales Market Share by Country (2020-2031)

Figure 45. Latin America Aesthetic Injectables Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Aesthetic Injectables Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Aesthetic Injectables Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Aesthetic Injectables Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Aesthetic Injectables by Type (2020-2031)

Figure 55. Global Revenue Market Share of Aesthetic Injectables by Type (2020-2031)

Figure 56. Global Aesthetic Injectables Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Aesthetic Injectables by Application (2020-2031)

Figure 58. Global Revenue Market Share of Aesthetic Injectables by Application (2020-2031)

Figure 59. Global Aesthetic Injectables Price (US$/Unit) by Application (2020-2031)

Figure 60. Aesthetic Injectables Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions